Evidence map›Paper›PMID 42787874›Full record

ArticleWorld journal of nuclear medicine2026

Limited Added Prognostic Value of Choline PET/CT in Treatment-Naïve Hepatocellular Carcinoma.

Irina Vierasu, Hugo Levillain, Martina Pezzullo, Jennifer Dhont, Hugues Azema, Hugo Couvert, Clémentine Marin, Nicola Trotta, Simon Lacroix, Ana-Maria Bucalau and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Irina VierasuNuclear Medicine Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-0640-0916
Hugo LevillainMedical Physics Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Martina PezzulloDepartment of Radiology, Hôpital Erasme, Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Jennifer DhontMedical Physics Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Hugues AzemaNuclear Medicine Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Hugo CouvertDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0001-8536-1259
Clémentine MarinMedical Physics Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Nicola TrottaMedical Physics Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-0871-1822
Simon LacroixNuclear Medicine Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Ana-Maria BucalauDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Gontran VersetDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Anne DemolsDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Marianne PaesmansInformation Management Unit, Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Desislava GermanovaLiver Transplant Unit, Department of Abdominal Surgery, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Valerio LucidiLiver Transplant Unit, Department of Abdominal Surgery, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Eric TrépoDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Thierry GustotDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Christophe MorenoDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Jean-Luc Van LaethemDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Patrick FlamenNuclear Medicine Department, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This retrospective study aimed to assess whether choline PET/CT provides additional independent prognostic value compared with magnetic resonance imaging (MRI) and [ Results: Higher than median MRI-, choline and [ Conclusion: Choline PET/CT did not demonstrate additional independent prognostic value beyond MRI or [

Indexed as

[ 18 F]FDG PET/CTcholine PET/CThepatocellular carcinomaMRIprognostic imaging biomarkers

Identifiers

PMID42787874
PMCPMC13612106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.